# PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder

> **NCT07121621** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 30 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)
- Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2)
- Methylphenidate
- Obesity &Amp; Overweight

## Interventions

- **DRUG:** PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity.

## Key facts

- **NCT ID:** NCT07121621
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-09-02
- **Final completion:** 2026-09-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07121621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07121621, "PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07121621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
